IP Library › Granted Patent US 8,691,750
Granted Patent B2
US 8,691,750 · App. 13/466,640 · Granted Apr 8, 2014

Lipids and compositions for intracellular delivery of biologically active compounds

Inventors: Rainer Constien (Schäftlarn, DE); Anke Geick (Bayreuth, DE); Philipp Hadwiger (Kulmbach, DE); Torsten Haneke (Kulmbach, DE); Ludger Markus Ickenstein (Kulmbach, DE); Carla Alexandra Hernandez Prata (Bamberg, DE); Andrea Schuster (Bayreuth, DE); Timo Weide (Burgkirchen, DE)
Assignee: Axolabs GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,691,750
App. No.
13/466,640
Filed
May 8, 2012
Granted
Apr 8, 2014
Kind
B2
Art Unit
1675
USPC
514/1.1
Abstract

The present invention provides novel amino-lipids, compositions comprising such amino-lipids and methods of producing them. In addition, lipid nanoparticles comprising the novel amino-lipids and a biologically active compound are provided, as well as methods of production and their use for intracellular drug delivery.

Claims (13)

1. A linear amino-lipid having the structure:

2. A lipid nanoparticle comprising an amino-lipid of claim 1 and an additional lipid selected from the group consisting of: cationic lipid, helper lipid, and PEG-lipid.

3. The lipid nanoparticle of claim 2 further comprising a hydrophobic small molecule.

4. The lipid nanoparticle of claim 2 further comprising a biologically active compound.

5. The lipid nanoparticle of claim 4 wherein the biologically active compound is selected from the group consisting of: small molecule, peptide, protein, carbohydrate, nucleic acid, and lipid.

6. The lipid nanoparticle of claim 2 , wherein the cationic lipid is a lipid comprising a quaternary amine with a nitrogen atom having four organic substituents.

7. The lipid nanoparticle of claim 2 , wherein the helper lipid is a neutral zwitterionic lipid.

8. The lipid nanoparticle of claim 3 , wherein the hydrophobic small molecule is selected from the group consisting of: a sterol and a hydrophobic vitamin.

9. The lipid nanoparticle of claim 3 , wherein the hydrophobic small molecule is cholesterol.

10. The lipid nanoparticle of claim 5 , wherein the peptide is a cell penetrating peptide.

11. The lipid nanoparticle of claim 5 , wherein the protein is selected from the group consisting of nucleoprotein, mucoprotein, lipoprotein, synthetic polypeptide, a small molecule linked to a protein, and glycoprotein.

12. The lipid nanoparticle of claim 5 , wherein the nucleic acid is in the form of a single stranded or partially double stranded oligomer or a polymer composed of ribonucleotides.

13. The lipid nanoparticle of claim 5 , wherein the nucleic acid is selected from the group consisting of miRNA, antisense oligonucleotides, siRNA, immune-stimulatory oligonucleotides, aptamers, ribozymes, and plasmids encoding a specific gene or siRNA.

Assignments (4)
CERTIFICATE Recorded Mar 1, 2013
From: F. HOFFMANN-LA ROCHE AG
To: F. HOFFMANN-LA ROCHE LTD
Reel/Frame 029903/0628 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2013
From: CONSTIEN, RAINER; GEICK, ANKE; HADWIGER, PHILIPP; HANEKE, TORSTEN; ICKENSTEIN, LUDGER MARKUS; HERNANDEZ PRATA, CARLA ALEXANDRA; SCHUSTER, ANDREA; WEIDE, TIMO
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 029905/0958 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2013
From: F. HOFFMANN-LA ROCHE LTD
To: ARROWHEAD RESEARCH CORPORATION
Reel/Frame 029906/0069 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2013
From: ARROWHEAD RESEARCH CORPORATION
To: AXOLABS GMBH
Reel/Frame 029906/0090 →
Priority Claims (1)
EP 11166353 · May 17, 2011 · regional
Continuity (1)
Related Publication 20120295832A1 · Nov 22, 2012